Clinical trial
Rituximab + Standard CHOP (R･S-CHOP) vs Rituximab+ Bi-weekly CHOP (R･Bi-CHOP) RCT(Phase II/III) for Stage III/IV Low-grade B-cell Lymphoma (LowBNHL-RS/BiCHOP-P2/3) (JCOG0203)
NCT00147121 is registered in ClinicalTrials.gov with Haruhiko Fukuda as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Rituximab + Standard CHOP (R･S-CHOP) vs Rituximab+ Bi-weekly CHOP (R･Bi-CHOP) RCT(Phase II/III) for Stage III/IV Low-grade B-cell Lymphoma (LowBNHL-RS/BiCHOP-P2/3) (JCOG0203)
- Lead sponsor
- Haruhiko Fukuda
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- September 30, 2002
- Completion date
- February 28, 2010
- Enrollment
- 300 (actual)
- Sites
- 45
Conditions
As the registry lists them; a condition with its own page is linked.